Glutathione in overweight patients with poorly controlled type 2 diabetes

Journal of Trace Elements in Experimental Medicine

Volumn 13, Issue 1, 2000, Pages 105-111

  Aaseth, Jan ^a   Stoa Birketvedt, Grethe ^b  

^a NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Diabetic complications; Free radicals; Glutathione peroxidase; Selenium

Indexed keywords

CELL PROTEIN; GLUTATHIONE; HEMOGLOBIN A1C; SULFONYLUREA;

ADULT; BODY MASS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIET THERAPY; ERYTHROCYTE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 0033966890     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-670X(2000)13:1<105::AID-JTRA12>3.0.CO;2-B     Document Type: Conference Paper

References (28)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352: 837-853.
3. Schleicher ED, Wagner E, Nerlich AG. Accumulatioin of the glucoxidation product N-(carboxymethyl)-lysin in human tissues in diabetes and aging. J Clin Invest 1997;99:457-468.
4. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990;173: 932-1939.
5. Baynes IW. Role of oxydative stress in development of complications in diabetes.Diabetes 1991;405-412.
6. Ha H, Yoon SJ, Kim KH. High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int 1994;46:1520-1626.
7. Cohen G. The Fenton reaction. In: Greenwald RA, editor. CRC handbook of methods for oxygen radical research. Boca Raton: CRC Press; 1985. p 55.
8. Aaseth J, Korkina LG. Afanas'ev IB: hemolytic activity of copper sulfate as influenced by epinephrine and chelating thiols. Acta Pharmacol Sin 1998;19:203-206.
9. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Application to mammalian blood and other tissues. Anal Biochem 1969;27:502-521.
10. Aaseth J, Alexander J, Norseth T. Uptake of chromate by human erythrocytes - a role of glutathione. Acta Pharmacol Toxicol 1982;50:310-315.
11. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: Regulation of glutathione synthesis and efflux. Diabetologia 1995;38:201-210.
12. Kashiwagi A, Asahina T, Nishio Y, Ikebushi M, Tanaka Y, Kikkawa R, Shigeta Y. Glycation, oxidative stress and scavenger activity: Glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 1996;45(suppl 3):884-886.
13. Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997;46(suppl 2):31-37.
14. Bravi MC, Pietrangeli P, Laurenti O, Basisli S, Cassone-Faldetti M, Ferri C, DeMattia G. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism 1997;46:1194-1198.
15. Jocelyn JC. Biochemistry of the SH group. London: Academic Press; 1972.
16. Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J ClLab Invest 1999;59:99-106.
17. Maxwell SRJ, Thomason H, Sandler D, LeGuen C, Baxter MA, Thorpe GHG, Jones AF, Barnett AH. Poor glycemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 1997;34:638-644.
18. Berg TJ, Nourooz-Zadeh J, Wolfe SP, Tritschler HJ, Bangstad HJ, Hanssen HJ. Hydroperoxides in plasma are reduced by intensified insulin treatment: A randomized controlled study of IDDM patients with microalbuminuria. Diabetes Care 21:1998;1295-1300.
19. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxydant treatment in experimental diabetic neuropathy. Diabetes 1997;46(Suppl 2):38-42.
20. Salonen TJ, Tuomainen TP, Nyssønen K, Lakka HM, Punnonen K. Br Med J 1998;317:727-727.
21. Busse E, Zimmer G, Schopohl B, Kornhuber B. Influence of alpha-lipoic acid on intra cellular glutathione in vitro and in vivo. Arzneimittel-Forschung 1992;42:829-831.
22. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as biological antioxidant. Free Radical Biol Med 1995;19:227-250.
23. Chopra M, Beswick H, Clapperton M, Dargle J, Smith WE, McMurrey J. Antioxidant effects of ACE inhibitors. J Cardiovasc Pharmacol 1992;19:330-340.
24. Gazis A, Page SR, Cockcroft JR. ACE-inhibitors, diabetes and cardiovascular disease. Diabetologia 1998;41:595-597.
25. Paolisso G, D'Amore A, Galzerano D, Balbi B, Giugliano D, Varrichio M, D'Onofrio F. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993;16:1433-1437.
26. Jeejeebhoy KN, et al. Am J Clin Nutr 1997;27:505-507.
27. Yonoha M, Ohbayashi Y, Noto N, Itoh E, Chiyama M. Effects of trivalent end hexavalent chromium on lipid peroxidation in rat liver microsomes. Chem Pharm Bull 1980;28:893-899.
28. 26: Aaseth J, Benov J, Ribarov S. Mercaptodextran-a new copper chelator and scavanger of oxygen radicals. Acta Pharmacol Sin 1990;363-367.